Asthma is a chronic inflammatory pulmonary disease and respiratory syncytial virus (RSV) infection is a common cause of lower respiratory tract illness in infants and young children. α-Asarone presents many pharmacological effects and has been demonstrated to be useful in treating asthma. However, the functional mechanism of α-asarone in RSV-infected asthma has not been investigated. Long non-coding RNAs (lncRNAs) have been reported to play critical roles in many biological processes. Although many lncRNAs have been characterized, few were reported in asthma, especially in RSV-induced asthma. Currently, a novel post-transcriptional regulation has been proposed in which lncRNAs function as competing endogenous RNAs (ceRNAs) to competitively sponge miRNAs, thereby regulating the target genes. In the present study, we established an RSV-infected Sprague-Dawley rat model and demonstrated that lncRNA-PVT1 is involved in the mechanism of α-asarone in treating RSV-induced asthma, and lncRNA-PVT1 regulates the expression of E2F3 by functioning as a ceRNA which competitively sponges miR-203a.
Introduction
Asthma is a chronic inflammatory pulmonary disease which is characterized by airway hyper-responsiveness to allergens, airway edema, and increased mucus secretion [1] . It has been reported that respiratory syncytial virus (RSV) infection is a high-risk factor for childhood asthma [2] [3] [4] . Although asthma control has been considerably improved through the administration of anti-inflammatory therapy such as inhaled glucocorticoids, the accompanied side-effects, and steroid resistance of these glucocorticoids make curative efficiency still remain unsatisfied [5] . Therefore, exploring novel treatment is essential for asthma.
α-Asarone, one of the main efficient ingredients in Acorus gramineus Soland, presents many pharmacological effects including antihperlipidemic, anti-inflammatory, and antioxidant activities [6, 7] . It has been demonstrated that α-asarone could be used to treat asthma [8, 9] . However, the function and mechanism of α-asarone in RSV-induced asthma has not been clearly elucidated.
Long non-coding RNAs (lncRNAs), a class of non-coding RNA with >200 nucleotides, have been identified as gene regulators involved in regulating multiple biological processes including proliferation, differentiation, apoptosis, and metastasis in many diseases, including asthma [10] [11] [12] [13] [14] [15] [16] [17] . Airway smooth muscle (ASM) has been identified as a key player in the pathogenesis of airway remodeling and the proliferation/migration of ASM cells (ASMCs) is associated with the remodeling and irreversible obstruction of airways during severe asthma [18] [19] [20] [21] . The aim of current study is to explore the possible lncRNA mechanism underlying α-asarone treatment for RSV-induced asthma in ASMCs derived from RSV-rats. We first established and identified an RSV-infection-induced asthmatic rat model, and then examined the function of α-asarone in RSV-derived ASMCs, and screened out the associated lncRNA-PVT1. By the loss-of-function and rescue assays, we proved that lncRNA-PVT1/ miR-203a/E2F3 is involved in the function of α-asarone in treating RSV-induced asthma.
Materials and Methods

Establishment of RSV-rat chronic asthmatic model
All experimental procedures were carried out in accordance with the NIH Guidelines for the Care and Use of Laboratory Animals and were approved by the Institutional Animal Care and Use Committee of Longhua Hospital. The animals were treated in accordance with the National Animal Welfare and Protection Law of China. Specificpathogen-free juvenile female Sprague-Dawley (SD) rats (60-80 g) obtained from the Experimental Animal Center of Longhua Hospital were randomly divided into three groups: the negative control group (n = 10), the RSV-infected group (n = 10), and the positive control ovalbumin (OVA) group (n = 10). The RSV model was constructed as follows: rats were intraperitoneally injected with 1 ml sensitization fluid (1% OVA and 100 mg aluminum hydroxide) at the 1st and 14th day, from Day 15, rats were aerosolly inhaled with 1% OVA (2 l/min) in an airtight container for 3 weeks, and the drip of the 1×10 6 PFU/100 μl/time was inhaled into the rats nasal cavity at the 28th, 31st, and 34th day, respectively. The OVA model was constructed according to reported literature [17] . In the control group, rats were injected with an equal volume of phosphate buffered saline (PBS). After being sensitized, the rats showed symptoms of asthmatic attack such as agitation, bucking, cyanosis, tachypnea, and so on. The rats were sacrificed within 24 h after the final challenge in each group and the specimen were collected for pathological examination and in situ hybridization.
Airway resistance measurement
Airway hyper-responsiveness was determined using the Buxco systems equipped with Buxco FinePointeTM body plethysmograph, pressure sensor, flow sensor, signal amplifier, and atomizer, as well as the software. The rats were placed in the plethysmograph, adapted for 5 min, and then stimulated with different concentrations of methacholine. All the Penh-values were recorded.
Isolation and culture of RSV-rat ASMCs
ASMCs were isolated from the airway of RSV SD rat (RSV-ASMCs) as reported by Zhao et al. [22] . The rat tracheal was dissected under sterile conditions in normal saline solution. Airways without cartilages were selected and airway smooth muscle bundles were micro-dissected free from surrounding tissues. The epithelial layer was removed. The smooth muscle section was digested with enzymes and then cells were collected. Cells were seeded in sterile 25-ml culture flasks containing 3 ml Dulbecco's modified Eagle's medium supplemented with 10% FBS, 100 U/ml penicillin, and 100 μg/ml streptomycin, and cultured at 37°C in humidified air containing 5% CO 2 .
Cell transfection
Cells were transfected with pcDNA3.1/PVT1, sh-PVT1, or E2F3 using Lipofectamine 2000 (Invitrogen, Carlsbad, USA) according to the manufacturer's protocol. Cell transfection with miR-203a mimics or inhibitor was performed using RNA mate (Genepharma, Shanghai, China) according to the manufacturer's protocol. PcDNA3.1/PVT1, sh-PVT1, E2F3, and miR-203a mimics or inhibitors were synthesized by the Genechem Company (Shanghai, China).
Cell proliferation assay
Cell proliferation ability was measured using the cell proliferation ELISA BrdU kit (Roche, Burgess Hill, UK). BrdU incorporation into cells with indicated vectors was quantitatively measured according to the standard manufacturer's protocol.
Cell viability assay
Cell viability was measured by 3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyl-trtrazolium bromide (MTT) assay. Cells (5×10 3 cells/well)
were seeded in the wells of a 96-well flat-bottomed plate and incubated for 24 h, then transfected with indicated vectors and cultured in normal medium. At 0, 24, 48, 72, and 96 h after transfection, 20 μl of MTT solution (5 mg/ml) were added to each well. After 4 h of incubation, the medium was removed and 100 μl DMSO was added to each well. The relative number of surviving cells was assessed by measuring the optical density of the wells at 560 nm. All assays were performed in triplicate.
Cell migration assay
Cell migration assay was measured using Transwell chambers (8-μm pore size; Corning Co., Corning, USA) with or without Matrigel (5 mg/ml; Becton Dickinson, Franklin Lakes, USA) coating. Fortyeight hours after transfection, cells in serum-free media were placed into the upper chamber coated with or without Matrigel. Media containing 10% FBS were added into the lower chamber. After 48 h of incubation, cells remained in upper membrane were wiped, and cells migrated or invaded were fixed with methanol, stained with 0.1% crystal violet and counted under a microscope. Three independent experiments were carried out.
Dual luciferase reporter assay
pmirGLO, pmirGLO-PVT1-wild-type (WT), or pmirGLO-PVT1-Mut (miR-203a) were co-transfected with miR-203a mimics or miRNA NC into HEK-293 cells by Lipofectamine-mediated gene transfer. The relative luciferase activity was normalized to Renilla luciferase activity after 48 h of transfection. Data were expressed as the relative fold change to the corresponding control groups, which were defined as 1.0.
Western blot analysis
Total cell lysates were separated by 10% sodium dodecyl sulfatepolyacrylamide gel electrophoresis, and were electrophoretically transferred to polyvinylidene difluoride membranes (Roche). Membranes were blocked with 5% (v/v) non-fat milk and then incubated with the primary antibodies in 5% (w/v) bovine serum albumin at 4°C overnight, followed by incubation with the corresponding horseradish peroxidase-conjugated secondary antibodies (Abcam, Cambridge, UK). Finally, membranes were washed three times for 15 min and the signals were detected using an enhanced chemiluminescence-detecting kit (Thermo Fisher, Waltham, USA), followed by analysis with Tanon 5200 Chemiluminescent Imaging System (Bio-Tanon, Shanghai, China). Primary antibodies used are antibodies against E2F3 (1:2000 dilution) and GAPDH (1:3000) which were obtained from Abcam (Cambridge, UK).
Quantitative real-time-polymerase chain reaction
Total RNA from tissues and cells was isolated using Trizol reagent (Invitrogen) according to the manufacturer's instructions. cDNA synthesis was performed according to the manufacturer's instructions (TaKaRa, Dalian, China). Quantitative real-time-polymerase chain reaction (qRT-PCR) was performed with SYBR Prime Script RT-PCR kit (TaKaRa) according to the manufacturer's instructions. The primers used are as follows: PVT1 forward: 5′-GCCCCTTCTATGGGAAT CACTA-3′, reverse: 5′-GGGGCAGAGATGAAATCGTAAT-3′; E2F3 forward: 5′-ACAAACAACCAAGACCACAATG-3′, reverse: 5′-GGG AGGCAGTAAGTTCACAAAC-3′; miR-203a forward: 5′-ATCCAGTG CGTGTCGTG-′, reverse: 5′-TGCTGTGAAATGTTTAGGA-3′; GAP DH forward: 5′-GGAGCGAGATCCCTCCAAAAT-3′, reverse: 5′-GGCTGTTGTCATACTTCTCATGG-3′; and U6 forward:5′-GCG CGTCGTGAAGCGTTC-3′, reverse: 5′-GTGCAGGGTCCGAGGT-3′. The levels of miRNAs and lncRNAs as well as the messenger RNA (mRNA) level of E2F3 were calculated using the 2 −ΔΔCt method, which was normalized to U6 and GAPDH, respectively. All assays were performed in triplicate. The expression levels were expressed as the relative fold change to the corresponding controls, which were defined as 1.0.
RNA immunoprecipitation assay
RNA immunoprecipitation (RIP) experiments were performed as reported by Ding et al.
[23] using a Magna RIP RBP immunoprecipitation kit (Millipore, Billerica, USA) according to the manufacturer's instructions. Briefly, RSV-ASMCs at 80%-90% confluency were scraped off and lysed in complete RIP lysis buffer. Then, 100 μl of whole cell extract was incubated with RIP buffer containing magnetic beads conjugated with human anti-Ago2 antibody (Abcam). Normal mouse IgG (Abcam) was used as the negative control. Samples were incubated with proteinase K with shaking to digest the protein, and then immunoprecipitated (IP) RNA was isolated. RNA concentration was measured using a NanoDrop pectrophotometer (Thermo Fisher), and RNA quality was determined using a bioanalyzer (Agilent, Santa Clara, USA). The RNA from the IP materials was further measured by qPCR analysis as above.
Statistical analysis
All experiments were performed at least three times, and data were presented as the mean ± SD. The SPSS 17.0 software (SPSS Inc., Chicago, USA) was used for statistical analysis. Two group comparisons were performed with a Student's t-test or independent t-test.
Multiple group comparisons were analyzed with one-way ANOVA. All tests performed were two-sided. Statistically significant positive correlation between PVT1 and miR-203a (or E2F3) expression levels in 10 cases of RSV-infected SD rats was analyzed by Spearman's correlation analysis. P < 0.05 was considered statistically significant.
Results
Identification of RSV-induced asthmatic rat model
To investigate the function of α-asarone in RSV-induced asthma, RSV-induced asthmatic SD rat model was established. The expression of RSV in different groups was measured using in situ hybridization. As shown in Fig. 1A , compared with the PBS negative control and OVA positive control, the bronchial bronchiolar, epithelium cells, and alveolar epithelial cells of RSV-infected rats showed obviously RSV positive signal (claybank color). Furthermore, pathomorphology results (Fig. 1B) showed that the airway wall and the airway fold were significantly thickened, compared with the PBS negative control and OVA positive control. Additionally, compared with the PBS negative control and OVA positive control, the airway reactivity Penh-value of RSV-infected rats was significantly increased in an acetylcholine (ACH)-concentration-dependent manner ( Fig. 1C and Table 1 ). Moreover, the secretion of IL-4, IL-5, and IL-13 in BALF further confirmed the above results (Fig. 1D) .
Collectively, these data demonstrated that the RSV-induced asthmatic rat model was successfully established.
α-Asarone relieved asthma of RSV-rats and suppressed the proliferation and migration of RSV-ASMCs
In order to explore the function and mechanism of α-asarone in RSV-induced asthma, RSV-infected rats were treated with α-asarone. As shown in Fig. 2A and Table 2 , the airway reactivity Penh-value of α-asarone-treated rats was significantly decreased, compared with that of the control (without treatment of α-asarone).
Pathomorphology results showed that the airway wall and the airway fold were significantly thinned compared with the control (Fig. 2B) . Additionally, treatment of RSV-rats with α-asarone could significantly inhibit the secretion of IL-4, IL-5, and IL-13 in BALF (Fig. 2C) . To further investigate the function of α-asarone, the effect of different concentrations of α-asarone on the viability, proliferation, and migration of normal-ASMCs and RSV-ASMCs, respectively was detected. As shown in Fig. 2D ,E, weakened cell viability, proliferation ability and migration capacity was observed in RSVASMCs treated with α-asarone (5 and 10 μM) compared with the control, while no significant effect was seen in normal-ASMCs. These results indicated that α-asarone could affect RSV-ASMC viability, proliferation, and migration in a concentrated-dependent manner.
LncRNA-PVT1 was down-regulated in RSV-ASMCs after α-asarone treatment
It has been reported that lncRNAs are involved in the progression of asthma. Therefore, the levels of six lncRNAs (LINC00882, LINC00883, PVT1, RP11-46A10.4, BCYRN1, and GAS5) which are associated with asthma or ASMCs in RSV-rats were detected. As shown in Fig. 3A , the levels of BCYRN1, GAS5, and PVT1 were significantly increased in RSV-ASMCs compared with the normal ASMCs. Then RSV-ASMCs were also treated with α-asarone. As shown in Fig. 3B , PVT1 was obviously downregulated, while the levels of BCYRN1 and GAS5 showed little change in response to the treatment with α-asarone, indicating that PVT1 may be the target regulated by α-asarone. To detect the effect of PVT1 on the viability, proliferation, and migration of RSV-ASMCs, RSV-ASMCs were transfected with sh-PVT1. As shown in Fig. 3C -E, weakened cell viability, proliferation ability, and migration capacity was observed in RSV-ASMCs transfected with sh-PVT1, compared with the negative control. These data indicated that PVT1 played a critical role in the viability, proliferation, and migration of RSV-induced ASMC, and that PVT1 may be a target regulated by α-asarone.
MiR-203a is a target of lncRNA-PVT1 and mediates the function of lncRNA-PVT1 in RSV-ASMCs
To further investigate the regulating pathway of α-asarone, the downstream target genes of PVT1 were explored. Many studies [24] [25] [26] [27] [28] have shown that some lncRNAs function as miRNA sponges, i.e. as competing endogenous RNAs (ceRNAs), and are able to reduce the amount of miRNAs targeting at mRNAs. We hypothesize that PVT1 may function in RSV-ASMCs through competitively sponging miRNAs. To confirm the ceRNA role of PVT1, RSV-ASMCs were transfected with si-Dicer gene to interfere the function of miRNAs. Satisfactory transfection efficiency was obtained as revealed by qRT-PCR at 48 h post-transfection ( Fig. 4A ; P < 0.01). Compared with negative group, the viability, proliferation, and migration capacity of RSV-ASMCs transfected with siDicer were significantly increased (Fig. 4B,C Table S1 ). Therefore, the expression levels of these 23 miRNAs in PVT1 were measured in downregulated ASMCs cells and control cells. Results showed that four miRNAs were upregulated by >3-folds in PVT1-downregulated ASMCs cells compared with control cells. The four miRNAs expression levels were further examined in response to α-asarone. Based on the results from Fig. 4D , we focused on miR-203a which P < 0.01 versus PBS. The data were shown as the mean ± SD (n = 5). exhibited the greatest change. Then, RIP assay and dual luciferase reporter assay were performed to further validate the regulatory relationship between PVT1 and miR-203a. As shown in Fig. 4E , RIP assay revealed that overexpression of PVT1 in RSV-ASMCs led to increased enrichment of Ago2 on PVT1, and the results from dual luciferase reporter assays proved that miR-203a mimics reduced the luciferase activity of WT PVT1 reporter vector but not that of empty vector and mutant reporter vector (Fig. 4F) . These data confirmed a direct binding between PVT1 and miR-203a. Additionally, rescue assays were performed. RSV-ASMCs were transfected with empty vector, miR-203a mimics and pcDNA3.1/ PVT1. As shown in Fig. 4G ,H, increased cell viability, proliferation ability, and enhanced migration capacity were observed in cells cotransfected with miR-203a mimics and pcDNA3.1/PVT1, compared with cells transfected with miR-203a mimics only. These data indicated that PVT1/miR-203a may be involved in mediating the function of α-asarone.
E2F3 is a downstream target of PVT1/miR-203a
It has been reported that E2F3 is a target of miR-203a, and E2F3 is involved in many biological processes. Therefore, we propose that PVT1 and E2F3 may interact with miR-203a by functioning as ceRNAs and the regulating pathway PVT1/miR-203a/E2F3 may mediate the function of α-asarone in RSV-rats. To confirm this, the mRNA level and the protein level of E2F3 were measured in response to the level of PVT1 and miR-203a, respectively. As shown in Fig. 5A ,B, downregulated PVT1 or overexpression of miR-203a significantly decreased the mRNA level and protein level of E2F3. Additionally, with the deletion of miR-203a, the effect of sh-PVT1 P < 0.01 versus PBS. The data were shown as the mean ± SD (n = 5). Figure 3 . LncRNA-PVT1 was downregulated in ASMCs after treatment with α-asarone (A) qRT-PCR was performed to measure the level of reported lncRNAs (LINC00882, LINC00883, PVT1, RP11-46A10.4, BCYRN1, and GAS5) associated with asthma or ASMCs in RSV-rats. (B) The levels of BYCYRN1, GAS5, and PVT1 in response to the treatment with α-asarone. (C-E) MTT assay, BrdU assay, and Transwell assay were performed to detect the function of PVT1 on the viability, proliferation ability, and migration capacity of ASMC. Data are presented as the mean ± SD of three independent experiments. N.S.: not significant. *P < 0.05, **P < 0.01 versus control group. on E2F3 was abolished (Fig. 5C) . Then, luciferase reporter assays were performed to confirm the interaction between miR-203a and E2F3. As shown in Fig. 5D , miR-203a could bind with the 3′-UTR of the E2F3 gene, and reduce the luciferase activity of WT E2F3 reporter vector but not that of empty vector or mutant reporter vector. Additionally, treatment of RSV-ASMCs with α-asarone could significantly suppress the level of E2F3 (Fig. 5E) . These findings indicated that E2F3 is involved in the PVT1/miR-203a signal pathway. qRT-PCR was performed to detect the effect of α-asarone on miRNAs expression. (E, F) RIP and dual luciferase activity assay were employed to confirm the interaction between PVT1 and miR-203a. (G, H) Rescue assay on cell viability, proliferation, and migration were performed. Data are presented as the mean ± SD of three independent experiments. *P < 0.05, and **P < 0.01 versus control group.
α-Asarone exerted its function through targeting the lncRNA-PVT1/miR-203a/E2F3 signal pathway To prove that the regulating pathway PVT1/miR-203a/E2F3 is involved in the function of α-asarone in RSV-rats, the treatment efficiency of α-asarone was detected when RSV-ASMCs were transfected with PVT1, miR-203a inhibitor, or E2F3, respectively. As shown in Fig.6A-C , the suppression effect of α-asarone in RSVASMCs could be partially reversed by introduction of PVT1, miR203a inhibitor, or E2F3, respectively. Furthermore, the levels of PVT1, miR-203a and E2F3 mRNA in 10 pairs RSV-infected rats with or without α-asarone treatment were examined. As shown in Fig. 6D , the levels of PVT1 and E2F3 mRNA were significantly decreased in the α-asarone-treated group, compared with the untreated group, while the level of miR-203a was obviously increased. Additionally, the expression level of miR-203a was negatively correlated with the level of PVT1, while the level of E2F3 mRNA was positively correlated with the level of PVT1 (Fig. 6E) . Collectively, these findings suggested that PVT1 functions as a ceRNA through competitively sponging miR-203a and regulating the expression of E2F3, which mediates the function of α-asarone in RSV-infected rats.
Discussion
In the present study, we explored the function of α-asarone in RSVinfected SD rats. Our results showed that treatment of ASMCs derived from RSV-infected SD rats with α-asarone could significantly weaken the viability, proliferation ability, and migration capacity of RSV-ASMCs, and such function is mediated by the PVT1/ miR-203a/E2F3 signal pathway.
RSV infection is a common cause of lower respiratory tract illness in infants and young children [29] . α-Asarone, a biological active component of the bark extracted from Guatteria gaumeri Greenman, has been used for the treatment of pneumonia, asthma, and grand mal seizuers [9, 30] . However, the mechanism of α-asarone function in RSV-infected asthma has not been investigated.
LncRNAs with >200 nucleotides have been reported to play critical roles in many biological processes at various levels, including chromatin modification, transcription, and post-transcriptional processing [31] [32] [33] [34] [35] . Although many lncRNAs have been characterized, few were reported in asthma, especially in RSV-induced asthma. In addition, the regulation function of miRNAs on ASM has also been discussed recently. For instance, in 2016, O'Leary et al. [30] demonstrated that airway smooth muscle inflammation is regulated by miR-145 in COPD; in 2013, Perry et al. [31] reported that airway smooth muscle hyperproliferation could be regulated by miR-221 in severe asthma; and in 2010, Larner-Svensson et al. [32] showed that interleukin-1β-induced miRNA-146a is associated with primary human airway smooth muscle. All these studies revealed that ncRNAs play essential roles in ASM. Currently, a novel post-transcriptional regulation has been proposed in which lncRNAs function as ceRNAs to competitively sponging miRNAs, thereby regulating the target genes [33] [34] [35] [36] [37] [38] [39] [40] [41] . Accumulating evidence has shown that endogenous transcripts including lncRNAs harboring miRNA response elements can function as competitive platforms for miRNAs and interact with each other through functioning as endogenous miRNA sponges or ceRNAs, forming a large-scale regulatory network across the transcriptome [42] [43] [44] .
In this study, we demonstrated that lncRNA-PVT1 is involved in the mechanism of α-asarone action in treating RSV-induced asthma, through functioning as a ceRNA to competitively sponging miR203a, thereby regulating the expression of E2F3. We first measured several lncRNAs associated with asthma (LINC00882, LINC00883, PVT1, RP11-46A10.4, BCYRN1, and GAS5) in normal-ASMCs and RSV-ASMCs, and found that the levels of three lncRNAs were significantly upregulated in RSV-ASMCs, but only the level of PVT1 was significantly changed in response to the treatment with α-asarone. PVT1, located adjacent to the MYC locus on chromosomal region 8q24, has been reported to be associated with many biological processes [45] [46] [47] [48] [49] . Therefore, we employed loss-of-function study to investigate the effect of PVT1 on RSV-ASMCs. We found that deletion of PVT1 significantly suppressed the viability, proliferation, and migration of RSV-ASMCs. And bioinformatics, RIP assay, luciferase activity assays, qRT-PCR, and western blot analysis results confirmed that miR-203a/E2F3 was downstream targets of PVT1. Additionally, we also examined the levels of miR-203a and E2F3 mRNA in response to the treatment with α-asarone. We found that treatment of RSV-ASMCs with α-asarone could significantly increase the level of miR-203a, but decrease the mRNA level of E2F3. Furthermore, rescue assay results revealed that the effect of α-asarone on ASMCs could be partially reversed by the introduction of PVT1, miR-203a inhibitor, or E2F3, respectively. Finally, we found that in 10 pairs RSV-infected rats with or without α-asarone treatment, the level of miR-203a was negatively correlated with the level of PVT1, while E2F3 was positively correlated with PVT1. All these results suggest that α-asarone exerts its function in RSV-infected SD rats through targeting the PVT1/miR-203a/E2F3 signal pathway.
In summary, we confirmed the function of α-asarone in RSVinfected asthma rat model and RSV-ASMCs and revealed that the PVT1/miR-203a/E2F3 signal pathway is involved in the function of α-asarone. Despite these findings, there are still some defects in the current study, for example: the relationship of PVT1, miR-203a, and E2F3 should be further confirmed in clinical tissues. The ultimate goal of our study is to provide new clues for the development of more efficient therapeutic agents.
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